-
Je něco špatně v tomto záznamu ?
Late morbidity following nerve-sparing radical hysterectomy
D. Cibula, P. Velechovska, J. Slama, D. Fischerova, I. Pinkavova, D. Pavlista, P. Dundr, M. Hill, P. Freitag, M. Zikan
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
Grantová podpora
NS10037
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
- MeSH
- anální kanál fyziologie MeSH
- dospělí MeSH
- hysterektomie metody škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- močový měchýř fyziologie inervace MeSH
- morbidita MeSH
- nádory děložního čípku chirurgie patologie MeSH
- prospektivní studie MeSH
- průzkumy a dotazníky MeSH
- rektum fyziologie MeSH
- senioři MeSH
- staging nádorů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
OBJECTIVES: Nerve-sparing (NS) modification of radical hysterectomy (RH) has been developed with the main purpose of improving the quality of life after radical surgical treatment of early-stage cervical cancer. Although the procedure has been discussed for almost 30 years, there are only limited data available on late morbidity. The aim of the study was to prospectively evaluate the morbidity of patients before and 6 months after NS RH and compare that with the morbidity in patients following different types of parametrectomy without nerve sparing. METHODS: Multiple parameters were assessed prospectively using 20-item self-reported questionnaire, focusing on three main areas of morbidity: bladder, sexual, and anorectal functions. Excluded were patients treated with adjuvant radiotherapy. RESULTS: Enrolled were women following NS RH (N=32), type C RH (N=19), and type D RH (N=21). Nine parameters significantly deteriorate in the whole group after the treatment: defecation straining (p=0.03), defecation regularity (p=0.0006), defecation frequency (p=0.02), need to use laxatives (p<0.001), flatulence incontinence (p<0.001), urinary incontinence (p<0.001), nocturia (p=0.002), loss of bladder sensation (p=0.04), and straining to void (p<0.001). There were significant differences (p<0.05) between groups following NS and type C or D RH in changes of following parameters: defecation regularity, receptivity to sexual activity, urinary incontinence, nocturia, and straining to void, while no differences were found between type C and D RH. Minimal changes were observed in any of 10 parameters of sexual functions. CONCLUSIONS: Our results confirmed a significant negative impact of RH on bladder and anorectal functions. Autonomic nerve preservation significantly improved morbidity 6 months after treatment.
- 000
- 03755naa a2200565 a 4500
- 001
- bmc12008610
- 003
- CZ-PrNML
- 005
- 20140519145318.0
- 008
- 120316s2010 xxu eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cibula, David, $d 1968- $7 jo20000074072 $u Oncogynecological Center, Department of Obstetrics and Gynecology, General Teaching Hospital in Prague, First Medical School, Charles University, Prague 2, Czech Republic. david.cibula@iol.cz
- 245 10
- $a Late morbidity following nerve-sparing radical hysterectomy / $c D. Cibula, P. Velechovska, J. Slama, D. Fischerova, I. Pinkavova, D. Pavlista, P. Dundr, M. Hill, P. Freitag, M. Zikan
- 520 9_
- $a OBJECTIVES: Nerve-sparing (NS) modification of radical hysterectomy (RH) has been developed with the main purpose of improving the quality of life after radical surgical treatment of early-stage cervical cancer. Although the procedure has been discussed for almost 30 years, there are only limited data available on late morbidity. The aim of the study was to prospectively evaluate the morbidity of patients before and 6 months after NS RH and compare that with the morbidity in patients following different types of parametrectomy without nerve sparing. METHODS: Multiple parameters were assessed prospectively using 20-item self-reported questionnaire, focusing on three main areas of morbidity: bladder, sexual, and anorectal functions. Excluded were patients treated with adjuvant radiotherapy. RESULTS: Enrolled were women following NS RH (N=32), type C RH (N=19), and type D RH (N=21). Nine parameters significantly deteriorate in the whole group after the treatment: defecation straining (p=0.03), defecation regularity (p=0.0006), defecation frequency (p=0.02), need to use laxatives (p<0.001), flatulence incontinence (p<0.001), urinary incontinence (p<0.001), nocturia (p=0.002), loss of bladder sensation (p=0.04), and straining to void (p<0.001). There were significant differences (p<0.05) between groups following NS and type C or D RH in changes of following parameters: defecation regularity, receptivity to sexual activity, urinary incontinence, nocturia, and straining to void, while no differences were found between type C and D RH. Minimal changes were observed in any of 10 parameters of sexual functions. CONCLUSIONS: Our results confirmed a significant negative impact of RH on bladder and anorectal functions. Autonomic nerve preservation significantly improved morbidity 6 months after treatment.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a senioři $7 D000368
- 650 02
- $a anální kanál $x fyziologie $7 D001003
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a lidé $7 D006801
- 650 02
- $a hysterektomie $x metody $x škodlivé účinky $7 D007044
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a morbidita $7 D009017
- 650 02
- $a staging nádorů $7 D009367
- 650 02
- $a prospektivní studie $7 D011446
- 650 02
- $a průzkumy a dotazníky $7 D011795
- 650 02
- $a rektum $x fyziologie $7 D012007
- 650 02
- $a močový měchýř $x fyziologie $x inervace $7 D001743
- 650 02
- $a nádory děložního čípku $x chirurgie $x patologie $7 D002583
- 650 02
- $a mladý dospělý $7 D055815
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1#
- $a Velechovská, P. $7 _AN054132
- 700 1_
- $a Sláma, Jiří $7 xx0105772
- 700 1_
- $a Fischerová, Daniela $7 xx0074804
- 700 1_
- $a Pinkavová, Ivana, $7 xx0103207 $d 1976-
- 700 1_
- $a Pavlišta, David $7 xx0057882
- 700 1_
- $a Dundr, Pavel $7 xx0080436
- 700 1_
- $a Hill, Martin, $d 1962- $7 mzk2005304431
- 700 1_
- $a Freitag, Pavel, $d 1951- $7 xx0018148
- 700 1_
- $a Zikán, Michal, $d 1976- $7 xx0096708
- 773 0_
- $t Gynecologic Oncology $p Gynecol Oncol $g Roč. 116, č. 3 (2010), s. 506-511 $w MED00001958 $x 0231-5882
- 773 0_
- $p Gynecol Oncol $g 116(3):506-11, 2010 Mar
- 910 __
- $a ABA008 $b x $y 4 $z 0
- 990 __
- $a 20120319124546 $b ABA008
- 991 __
- $a 20140519145501 $b ABA008
- 999 __
- $a ok $b bmc $g 901960 $s 765505
- BAS __
- $a 3
- BMC __
- $a 2010 $b 116 $c 3 $d 506-511 $m Gynecologic oncology $x MED00001958
- GRA __
- $a NS10037 $p MZ0
- LZP __
- $a 2012-1Q10/